Salivary Gland Cancer
📧 Sign up to get email alerts when something new happens for Salivary Gland Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas [Phase 2]
Phase 2 clinical trial evaluating post-operative T-DM1 in HER2-positive salivary gland carcinomas; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) [Phase 2]
This update reports completion of a Phase 2 trial of darolutamide in patients with androgen receptor–positive salivary gland carcinoma (DISC…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating a binary oncolytic adenovirus in combination with a HER2-specific autologous CAR-VST for advanced HER2-pos…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of nivolumab and ipilimumab in patients with salivary gland cancer has completed enrollm…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) [Phase 1]
Poseida Therapeutics conducted a Phase 1 trial of P-PSMA-101 CAR-T cells in metastatic castration-resistant prostate cancer and advanced sal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Androgen Deprivation Therapy in Advanced Salivary Gland Cancer [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating androgen deprivation therapy in patients with advanced salivary gl…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer [Phase 1]
Phase 1 trial of nab-paclitaxel (albumin-bound paclitaxel) with carboplatin followed by chemoradiation in patients with recurrent head and n…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors [Phase 2]
Phase 2 trial update from Genentech evaluating combinations of Herceptin, Perjeta, Tarceva, Zelboraf, Cotellic, Erivedge, Alecensa, and Tece…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab and ipilimumab with stereotactic body radiation therapy in salivary gland cancers; study status complet…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Activity of Sorafenib in Salivary Gland Cancer [Phase 2]
Phase 2 clinical trial update on sorafenib in salivary gland cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating Lutetium-177-PSMA radioligand therapy for advanced salivary gland cancers has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study [Phase 2]
A multicenter Phase II study evaluating weekly docetaxel plus cisplatin as first-line chemotherapy in metastatic salivary gland cancer is un…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas [Phase 2]
Phase 2 clinical trial update for Surufatinib in recurrent/metastatic head and neck adenocarcinomas (salivary gland origin) with unknown sta…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers [Phase 2]
Phase 2 trial update of abiraterone acetate in relapsed/metastatic salivary gland cancers completed.
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Stereotactic Body Radiotherapy for Head and Neck Tumors [Phase 4]
Phase 4 clinical trial update on stereotactic body radiotherapy for head and neck tumors with completed status and posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers [Phase 2]
Phase 2 trial results of enzalutamide in patients with androgen receptor–positive salivary gland cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 [Phase 2]
Phase 2 trial update of axitinib in relapsed/refractory salivary gland cancers of the upper aerodigestive tract has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Imatinib Mesylate in Treating Patients With Salivary Gland Cancer [Phase 2]
Phase 2 trial update of Imatinib Mesylate for salivary gland cancer (a form of head and neck cancer) has been completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer [Phase 2]
Phase 2 clinical trial evaluating eribulin mesylate in recurrent or metastatic salivary gland cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Iressa Study in Patients With Salivary Gland Cancer [Phase 2]
Phase 2 trial of Iressa (gefitinib) in salivary gland cancer has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer [Phase 2]
This clinical trial update summarizes a Phase 2 study of trastuzumab in patients with advanced salivary gland cancer, which has completed en…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 clinical trial update for SB-715992 in patients with recurrent or metastatic head and neck cancer; the study completed and results w…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Title XELOX FOR SALIVARY GLAND CANCERS [Phase 2]
Phase 2 study of the XELOX regimen (capecitabine plus oxaliplatin) for salivary gland cancers and head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery [Phase 2]
Phase 2 trial of gemcitabine for advanced, unresectable salivary gland cancer has completed.